Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity
- 31 March 1992
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 23 (2) , 235-239
- https://doi.org/10.1016/0306-3623(92)90017-e
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N‐methyl‐d‐aspartate or quisqualate, and the effects on toxicity of 2‐amino‐5‐phosphonovaleric acid and kynurenic acid in the ratBritish Journal of Pharmacology, 1991
- Sensitivity of hippocampal neurones to kainic acid, and antagonism by kynurenateBritish Journal of Pharmacology, 1990
- Identification and quantification of kynurenic acid in human brain tissueBrain Research, 1988
- Identification and measurement of kynurenic acid in the rat brain and other organsAnalytical Biochemistry, 1988
- Ia afferent excitation of motoneurones in the in vitro new‐born rat spinal cord is selectively antagonized by kynurenate.The Journal of Physiology, 1986
- Quinolinic acid and other kynurenines in the central nervous systemNeuroscience, 1985
- Effects of kynurenate on root potentials evoked by synaptic activity and amino acids in the frog spinal cordBrain Research, 1985
- Actions of excitatory amino acids and kynurenic acid in the primate hippocampus: A preliminary studyNeuroscience Letters, 1984
- Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acidNeuroscience Letters, 1984
- An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acidBrain Research, 1982